Literature DB >> 21654360

Update on fatty liver disease and steatohepatitis.

Fatima Zahra Aly1, David E Kleiner.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a broad term that includes liver diseases characterized by abnormal hepatocellular accumulations of lipid that cannot be related to alcohol abuse. It may be found in both adults and children, particularly those who are obese or have insulin resistance. Steatohepatitis is a specific pattern of injury within the spectrum of NAFLD and this pattern is associated with fibrotic progression and cirrhosis. In addition to steatohepatitis, a distinct form of fibrotic fatty liver disease exists in children. There have been a number of recent advances in the characterization of histologic changes in NAFLD. In light of these recent reports, this study will: (1) review the histologic features of steatosis and nonalcoholic steatohepatitis in adults; (2) review the variation of histologic patterns of pediatric fatty liver disease; and (3) discuss the validity and use of the nonalcoholic fatty liver disease Activity Score.

Entities:  

Mesh:

Year:  2011        PMID: 21654360      PMCID: PMC3140771          DOI: 10.1097/PAP.0b013e318220f59b

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  47 in total

Review 1.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

Review 2.  American College of Endocrinology position statement on the insulin resistance syndrome.

Authors:  Daniel Einhorn; Gerald M Reaven; Rhoda H Cobin; Earl Ford; Om P Ganda; Yehuda Handelsman; Richard Hellman; Paul S Jellinger; David Kendall; Ronald M Krauss; Naomi D Neufeld; Steven M Petak; Helena W Rodbard; John A Seibel; Donald A Smith; Peter W F Wilson
Journal:  Endocr Pract       Date:  2003 May-Jun       Impact factor: 3.443

3.  Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.

Authors:  I R Wanless; J S Lentz
Journal:  Hepatology       Date:  1990-11       Impact factor: 17.425

4.  Liver pathology in morbidly obese patients with and without diabetes.

Authors:  J F Silverman; K F O'Brien; S Long; N Leggett; P G Khazanie; W J Pories; H T Norris; J F Caro
Journal:  Am J Gastroenterol       Date:  1990-10       Impact factor: 10.864

5.  Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.

Authors:  Arun J Sanyal; Melissa J Contos; Richard K Sterling; Velimir A Luketic; Mitchell L Shiffman; R Todd Stravitz; A Scott Mills
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

Review 6.  Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

Authors:  Brent A Neuschwander-Tetri; Stephen H Caldwell
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

Review 7.  Mitochondria in nonalcoholic fatty liver disease.

Authors:  Stephen H Caldwell; Charissa Y Chang; Robert K Nakamoto; Lisa Krugner-Higby
Journal:  Clin Liver Dis       Date:  2004-08       Impact factor: 6.126

8.  Kupffer cell aggregation and perivenular distribution in steatohepatitis.

Authors:  Jay H Lefkowitch; Jennifer H Haythe; Nicole Regent
Journal:  Mod Pathol       Date:  2002-07       Impact factor: 7.842

9.  HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.

Authors:  Shivakumar Chitturi; Martin Weltman; Geoffrey C Farrell; David McDonald; James Kench; Christopher Liddle; Dev Samarasinghe; Rita Lin; Shehan Abeygunasekera; Jacob George
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

10.  Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease.

Authors:  Elizabeth M Brunt; Sunil Ramrakhiani; Barry G Cordes; Brent A Neuschwander-Tetri; Christine G Janney; Bruce R Bacon; Adrian M Di Bisceglie
Journal:  Mod Pathol       Date:  2003-01       Impact factor: 7.842

View more
  25 in total

1.  Adipocyte maturation arrest: a determinant of systemic insulin resistance to glucose disposal.

Authors:  Nicola Abate
Journal:  J Clin Endocrinol Metab       Date:  2012-03       Impact factor: 5.958

2.  Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.

Authors:  Yoon Mee Yang; Zhijun Wang; Michitaka Matsuda; Ekihiro Seki
Journal:  Arch Pharm Res       Date:  2021-01-24       Impact factor: 4.946

3.  A small supernumerary marker chromosome resulting in mosaic partial tetrasomy 4q26-q31.21 in a foetus with multiple congenital malformations.

Authors:  Zhi-Tao Zhang; Wen-Xu Qi; Cai-Xia Liu; Shao-Wei Yin; Yan Zhao; Jesse Li-Ling; Yuan Lv
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

Review 4.  Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening.

Authors:  Jeremy P Middleton; R Constance Wiener; Barrett H Barnes; Matthew J Gurka; Mark D DeBoer
Journal:  Clin Pediatr (Phila)       Date:  2014-01-28       Impact factor: 1.168

Review 5.  Pediatric non-alcoholic fatty liver disease: New insights and future directions.

Authors:  Pierluigi Marzuillo; Emanuele Miraglia Del Giudice; Nicola Santoro
Journal:  World J Hepatol       Date:  2014-04-27

Review 6.  Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease.

Authors:  Frank T Spradley; Jillian A Smith; Barbara T Alexander; Christopher D Anderson
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-06       Impact factor: 4.310

Review 7.  Pediatric fatty liver disease: role of ethnicity and genetics.

Authors:  Pierluigi Marzuillo; Emanuele Miraglia del Giudice; Nicola Santoro
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

8.  Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma.

Authors:  Srinevas K Reddy; Omar Hyder; J Wallis Marsh; Georgios C Sotiropoulos; Andreas Paul; Sorin Alexandrescu; Hugo Marques; Carlo Pulitano; Eduardo Barroso; Luca Aldrighetti; David A Geller; Christine Sempoux; Vlad Herlea; Irinel Popescu; Robert Anders; Laura Rubbia-Brandt; Jean-Francois Gigot; Giles Mentha; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2013-01-25       Impact factor: 3.452

Review 9.  Role of liver biopsy in nonalcoholic fatty liver disease.

Authors:  I L Ke Nalbantoglu; Elizabeth M Brunt
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 10.  Toxicant-associated steatohepatitis.

Authors:  Banrida Wahlang; Juliane I Beier; Heather B Clair; Heather J Bellis-Jones; K Cameron Falkner; Craig J McClain; Matt C Cave
Journal:  Toxicol Pathol       Date:  2012-12-21       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.